Stock Events

Stock Events

HADASIT BIO HOLDINGS NEW 

$0.12
2
-$1.47-92.45% Monday 21:00

Statistics

Day High
0.13
Day Low
0.13
52W High
0.13
52W Low
0.12
Volume
200
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Feb 19
$0.16
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30JunExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-0.15
0.01
0.18
0.34
Expected EPS
0
Actual EPS
0.3404

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-930,073.84Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HSITF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries Ltd. is a global leader in generic and specialty medicines, competing directly in the pharmaceutical and biotech sectors.
Redhill Biopharma
RDHL
Mkt Cap4.33M
RedHill Biopharma Ltd. operates in the same region and focuses on developing proprietary drugs for inflammatory and gastrointestinal diseases, overlapping with some of Hadasit's therapeutic areas.
Evogene
EVGN
Mkt Cap11.24M
Evogene Ltd. applies computational biology to develop products for life sciences and agriculture, competing in the biotech innovation space similar to Hadasit.
Kamada
KMDA
Mkt Cap402.48M
Kamada Ltd. is a biopharmaceutical company specializing in the development and production of plasma-derived protein therapeutics, a field relevant to Hadasit's interests in biopharmaceuticals.
Protalix BioTherapeutics
PLX
Mkt Cap188.97M
Protalix BioTherapeutics Inc. focuses on the development and commercialization of recombinant therapeutic proteins, which is a direct competition in the biopharmaceutical sector.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
BioMarin Pharmaceutical Inc. develops and commercializes innovative biopharmaceuticals for rare diseases, competing in the specialized biotech market similar to Hadasit.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals, Inc. is known for its innovation in biopharmaceuticals, directly competing with Hadasit in the field of novel medical solutions.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals Incorporated operates in the biotechnology and pharmaceuticals industry, focusing on serious diseases, thus competing in the same broad sector as Hadasit.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. is a leading biotech company focusing on areas like cardiovascular disease, oncology, and bone health, competing in the biopharmaceutical field.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. develops and markets therapies in areas such as liver disease, HIV, and oncology, overlapping with Hadasit's therapeutic focus areas.

About

Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It primarily focuses on the therapeutic areas, including oncology, regenerative medicine, and inflammatory disease. The company offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel.
Show more...
CEO
Mr. Yoram Azulai
Employees
2
Country
IL

Listings

TA
IL
HDST-M.TA

0 Comments

Share your thoughts

FAQ

What is HADASIT BIO HOLDINGS NEW stock price today?▼
The current price of HSITF is $0.12 USD — it has decreased by -92.45% in the past 24 hours. Watch HADASIT BIO HOLDINGS NEW stock price performance more closely on the chart.
What is HADASIT BIO HOLDINGS NEW stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange HADASIT BIO HOLDINGS NEW stocks are traded under the ticker HSITF.
Is HADASIT BIO HOLDINGS NEW stock price growing?▼
HSITF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year HADASIT BIO HOLDINGS NEW has showed a +0% increase.
What were HADASIT BIO HOLDINGS NEW earnings last quarter?▼
HSITF earnings for the last quarter are 0.34 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is HADASIT BIO HOLDINGS NEW revenue for the last year?▼
HADASIT BIO HOLDINGS NEW revenue for the last year amounts to 0 USD.
What is HADASIT BIO HOLDINGS NEW net income for the last year?▼
HSITF net income for the last year is -930,073.84 USD.
Does HADASIT BIO HOLDINGS NEW pay dividends?▼
Yes, HSITF dividends are paid annual. The last dividend per share was 0.16 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does HADASIT BIO HOLDINGS NEW have?▼
As of April 01, 2026, the company has 2 employees.
In which sector is HADASIT BIO HOLDINGS NEW located?▼
HADASIT BIO HOLDINGS NEW operates in the Health Care sector.
When did HADASIT BIO HOLDINGS NEW complete a stock split?▼
The last stock split for HADASIT BIO HOLDINGS NEW was on August 11, 2016 with a ratio of 1:10.
Where is HADASIT BIO HOLDINGS NEW headquartered?▼
HADASIT BIO HOLDINGS NEW is headquartered in Jerusalem, IL.